James Wassil, United States of America

Sutrovax Chief Operating Officer

Presenter of 1 Presentation

 Conference Calendar

DEVELOPMENT OF A NEXT GENERATION 24-VALENT PNEUMOCOCCAL CONJUGATE VACCINE USING SITE-SPECIFIC CARRIER PROTEIN CONJUGATION (ID 507)

Session Name
Vaccines - Pneumococcal Vaccines Development
Presenter
Authors

Author Of 1 Presentation

 Conference Calendar

DEVELOPMENT OF A NEXT GENERATION 24-VALENT PNEUMOCOCCAL CONJUGATE VACCINE USING SITE-SPECIFIC CARRIER PROTEIN CONJUGATION (ID 507)

Session Name
Vaccines - Pneumococcal Vaccines Development
Presenter
Authors